Kelsey E. Sivick - Department of Molecular and Cell Biology, University of California

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 36 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Casdatifan (AB521) is a Novel and Potent Allosteric Small Molecule Inhibitor of Protumourigenic HIF-2α Dependent Transcription

Patrick G Schweickert,Dana Piovesan, Casey G Mitchell, Bryan Zepeda-Carranza, Wandi S Zhu, Alejandra Y Lopez Espinoza, Lauren Rocha, Jaskirat Singh, Martin Ian P Malgapo,Cesar Meleza, Kyle R Northington, Rebecca D Ray, Xiaoning Zhao,Kenneth V Lawson, Matthew J Walters,Kelsey E Sivick

British journal of pharmacology (2025)

Cited0Views0WOSBibtex

Abstract A012: Discovery and Characterization of Casdatifan (AB521), a Clinical-Stage, Potent, and Selective Hypoxia-Inducible Factor (Hif)-2Α Inhibitor

Kenneth V. Lawson,Artur Mailyan,Guillaume Mata,Joel W. Beatty,Samuel L. Drew,Jeremy T. A. Fournier,Jaroslaw Kalisiak, Ahn T. Tran,Kai Yu,Brandon R. Rosen, Clayton Hardman, Matthew Epplin,Kelsey E. Sivick,Dana Piovesan,Suan Liu, Elain Ginn,Cesar A. Meleza,Lisa Seitz,Tzuling Cheng,Amber Pham, Mohammad Ghasemi,Paul G. Foster,Matthew J. Walters,Manmohan Leleti,Jay P. Powers

Molecular Cancer Therapeuticsno. 12_Supplement (2024)

Cited0Views0Bibtex

Activation of Human STING by a Molecular Glue-Like Compound

Jie Li,Stephen M. Canham,Hua Wu,Martin Henault, Lihao Chen, Guoxun Liu, Yu Chen,Gary Yu,Howard R. Miller,Viktor Hornak,Scott M. Brittain,Gregory A. Michaud,Antonin Tutter, Wendy Broom,Mary Ellen Digan,Sarah M. McWhirter,Kelsey E. Sivick,Helen T. Pham, Christine H. Chen, George S. Tria,Jeffery M. McKenna,Markus Schirle,Xiaohong Mao,Thomas B. Nicholson,Yuan Wang,Jeremy L. Jenkins,Rishi K. Jain,John A. Tallarico,Sejal J. Patel,Lianxing Zheng,Nathan T. Ross,Charles Y. Cho,Xuewu Zhang,Xiao-Chen Bai,Yan Feng

NATURE CHEMICAL BIOLOGYno. 3 (2024)

Cited11Views0WOSNATUREBibtex

Discovery and Characterization of Casdatifan (AB521), a Clinical-Stage, Potent, and Selective Hypoxia-Inducible Factor (Hif)-2Α Inhibitor

MOLECULAR CANCER THERAPEUTICSno. 12 (2024)

Cited0Views0Bibtex

Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity Without Depleting Regulatory T Cells

Dana Piovesan, Amber E. de Groot,Soonweng Cho,Amy E. Anderson, Rebecca D. Ray,Amita Patnaik,Paul G. Foster,Casey G. Mitchell, Alejandra Y. Lopez Espinoza, Wandi S. Zhu,Carlo E. Stagnaro,Hema Singh,Xiaoning Zhao,Lisa Seitz,Nigel P. Walker,Matthew J. Walters,Kelsey E. Sivick

CANCER RESEARCHno. 12 (2024): 1978-1995

Cited1Views0WOSBibtex

Supplemental Tables 1–3 from Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity Without Depleting Regulatory T Cells

crossref（2024）

Cited0Views0Bibtex

Figure S3 from TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors

Brian J. Francica,Ali Ghasemzadeh,Anthony L. Desbien,Debebe Theodros,Kelsey E. Sivick,Gabrielle L. Reiner,Laura Hix Glickman,Ariel E. Marciscano,Andrew B. Sharabi,Meredith L. Leong,Sarah M. McWhirter,Thomas W. Dubensky,Drew M. Pardoll,Charles G. Drake

openalex（2023）

Cited0Views0Bibtex

Figure S5 from TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors

openalex（2023）

Cited0Views0Bibtex

Figure S2 from TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors

openalex（2023）

Cited0Views0Bibtex

Figure S1 from TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn